Please login to the form below

Not currently logged in
Email:
Password:

Dr Reddy’s Laboratories founder passes away

Dr K. Anji Reddy loses cancer battle

Dr Reddy's Laboratories Dr K Anji ReddyDr K Anji Reddy, the founder and chairman of India's Dr Reddy's Laboratories died last week after a long battle with liver cancer.

The son of a turmeric farmer, he set up the company that bears his name in 1984 and grew the Hyderabad-based firm into one of India's leading pharmaceutical companies.

In 1993, it became the first initiate domestic firm to begin its own basic drug discovery research and, while this has yet to come to fruition, its generics business has gone from strength to strength.

His son, and current managing director of Dr Reddy's Laboratories, Satish Reddy said: “Dr Reddy touched millions of lives through his contribution to the pharmaceutical industry and his philanthropic efforts. In improving access to affordable, high quality medicines and in innovation, his contributions have been extraordinary.”

Dr K Anji Reddy was increasingly focused on philanthropy in the last 15 years, leading initiatives to provide safe rural drinking water and meals to school children and farmers.

Of late, the company has been run by his son K Satish Reddy, as managing director and COO, and his son-in-law G V Prasad, who is the vice chairman and CEO.

A BSc graduate from Bombay University with specialisation in Pharmaceutical Science and Fine Chemicals, Dr Reddy obtained his PhD in Chemical Engineering from National Chemical Laboratory, Pune.

Soon after his studies, he served in the state-owned IDPL before he founded his own company in 1984.

Dr Reddy served as a member of the Prime Minister's Council on Trade & Industry, Government of India and was honoured with one of India's highest civilian awards, the Padma Bhushan, in April 2011.

18th March 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
...
Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...

Infographics